Concerning the survival rates, Freier CP et al. studied 248 cases of cervical carcinoma and subsequently observed the association of the p53 mutation with a superior 5-year and 10-year survival prognostic, compared to those with negative p53 immunoexpression [34]. Here, TP53 is linked to cervical carcinoma.